Mepirapim, a novel synthetic cannabinoid, induces Parkinson’s disease-related behaviors by causing maladaptation of the dopamine system in the brain-Reference-Cited by-同舟云学术

Mepirapim, a novel synthetic cannabinoid, induces Parkinson’s disease-related behaviors by causing maladaptation of the dopamine system in the brain

Published:2022-11-10 Issue:2 Volume:97 Page:581-591
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Hur Kwang-Hyun,Lee Youyoung,Donio Audrey Lynn,Lee Jae-Gyeong,Lee Bo-Ram,Kim Seon-Kyung,Yoon Seolmin,Lee Yong-Sup,Kim Hyoung-Chun,Lee Seok-Yong,Jang Choon-Gon^ORCID

Funder

Korea Food and Drug Administration

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-022-03414-y.pdf

Reference44 articles.

1. Abbate V, Schwenk M, Presley BC, Uchiyama N (2018) The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure Appl Chem 90(8):1255–1282

2. Abush H, Akirav I (2012) Short-and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS ONE 7(2):e31731

3. Azzopardi JI, Ferry P (2020) Parkinson’s disease: current treatments and the possible use of Cannabis. Malta Med J 32(1):88–98

4. Babi M-A, Robinson CP, Maciel CB (2017) A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus—a case report and review of the literature. SAGE Open Me Case Rep 5:2050313X17745206

5. Barbieri M, Ossato A, Canazza I et al (2016) Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: behavioral, electrophysiological and neurochemical evidence. Neuropharmacology 109:254–269